ABSTRACT. To investigate the feasibility of establishing a neonatal screening program for familial type I1 hypercholesterolemia, we assayed apolipoprotein B (Apo B), using a radial immunodiffusion assay, in dried blood spot samples from 4491 consecutively born, 3-to 5-day-old neonates. We explored factors influencing levels at the time of sampling and factors associated with the handling of the dried blood spot samples before assay which could affect the assayed value. Assayed Apo B levels were distributed continuously and decreased with increasing delay and temperature of storage of the samples before assay. Female neonates had significantly higher mean Apo B levels than males (p < 0.0001), with their respective means 2 SD being 0.246 & 0.085 glliter (n = 2086) and 0.225 f 0.079 glliter of whole blood (n = 2390). In both sexes mean Apo B levels were significantly lower in low birth weight ( 5 2.5 kg) and in low gestational age ( r 36 wk)neonates. For neonates with birth weight > 2.5 kg and gestational age more than 36 wk, Apo B levels increased with increasing birth weight and gestational age. Sex, birth weight, and gestational age could account for 5.7% of the variability of Apo B. After adjustments for these variables, the neonate's age at sampling did not influence Apo B levels significantly. Apo B levels were not affected by different dietary regimens, whether breast-fed, formulafed, or breast-fed with formula complement. We concluded that dried blood spots should be stored frozen if there is to be any delay before assay and that although sex, birth weight, and gestational age contribute only a small amount to the variation in Apo B levels, their influence becomes important when determining a cut-off point for defining abnormal levels. (Pediatr Res 21: 608-614, 1987) Abbreviations FHII, familial type I1 hypercholesterolemia Apo B, apolipoprotein B LDL, low-density lipoprotein VLDL, very low-density lipoprotein R2, coefficient of multiple determination FHII is an autosomal dominantly inherited condition with an incidence of about one in 500 in the general population. It is characterized by elevated levels of LDL-cholesterol and the pre- Supported by the National Heart Foundation and the Ramaciotti Foundations.mature development of atherosclerosis, with myocardial infarction commonly occurring by the 4th or 5th decade of life. FHII is the most frequent inborn error of metabolism with serious consequences, and a neonatal screening program capable of detecting infants with FHII would provide prospects for the prevention of atherosclerosis by identifying young families at risk. A recent report from the Bogalusa Heart Study (1) showed a strong relationship between antemortem levels of LDL-cholesterol and the development of aortic fatty streaks in childhood. This supports the concept that atherosclerosis begins in childhood and suggests that primary prevention of atherosclerosis should begin early in life. Studies on the effects of cholesterollowering regimens in children have shown them to be safe, with growth...